Status: current, Defined. Date: 31-Jan 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1511091000168110 | betamethasone acetate 3 mg / 1 mL + betamethasone sodium phosphate 3.9 mg / 1 mL injection, 5 x 1 mL ampoules (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1511101000168117 | betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, 5 x 1 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, 5 x 1 mL ampoules | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, 5 x 1 mL ampoules | has MPUU | betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, ampoule | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Celestone Chronodose injection, 5 x 1 mL ampoules | Is a | True | betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, 5 x 1 mL ampoules | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR